The concept of dual antitumor action is further supported by findings that antibody drug conjugates (ADCs) directed to the target antigen CD276/B7-H3, which is expressed on both tumor cells and tumor vasculature, only effectively eradicate established tumors in mice when armed with a drug acting against tumor cells and simultaneously also the tumor vasculature [52]. Here, CD276 is linked to neoplasm.